Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 all comers meta-analysis

ChiCTR2000030054-HCQ (Chen)
 
ChiCTR2000030054
RCThydroxychloroquinestandard of careCOVID 19 all comershigh
18/12 inconclusive
    Gautret et al. NRahydroxychloroquinecontrolCOVID 19 all comersserious
    20/16 uncontrolled
    • [uncontrolled] virological cure (negative nasopharyngeal PCR): 70.0% (14/20)
    a viral load reduction/disappearance is claimed but the numerous methological limits preclude any strong conclusion

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).